in vitro News and Research

RSS

IVF improvements in United States

Since its introduction in the United States, assisted reproduction technology has helped allow women to conceive more than a million babies.

16 Apr 2004

Genetic mutation raises interesting questions about the evolution of the Y chromosome

The names and dates comprising a family tree contain branches that can extend backward centuries in time. People use these diagrams to discover their ancestral origin. Scientists use them to study the genealogical origins of entire species, tracing evolutionary history down to changes in a single gene.

14 Apr 2004

Growth hormones combat Crohn’s disease, cardiac disorders and improve fertility in invitro fertilisation

New treatments for breast cancer, skin and wound healing and obesity will be revealed at an international conference in Cairns, Australia next week.

13 Apr 2004

Antimicrobial alginate dressing protects the wound with silver

Johnson & Johnson Wound Management today announced the introduction of SILVERCEL™ antimicrobial alginate dressing, providing the protection of silver and the absorption of alginate.

13 Apr 2004

Prosthetic heart valve made completely of the body’s own tissue

Eight out of every 1000 children are born with a heart problem. Out of these, every fifth child needs a heart valve. While today’s mechanical or biological heart valves allow children to continue their lives, a research team at RWTH is developing a significantly more compatible heart valve that grows along with the body’s growth.

13 Apr 2004

New database for U.S. makers of in vitro diagnostic (IVD) medical devices

A new international database has been released that identifies measurement procedures and materials that will help U.S. makers of in vitro diagnostic (IVD) medical devices ensure that their products comply with European Union requirements.

9 Apr 2004

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

ProMetic Life Sciences Inc. has announced today that its joint venture with the American Red Cross, Pathogen Removal and Diagnostic Technology Inc. ("PRDT"), has confirmed that treatment of TSE spiked red blood cell concentrate with its Prion Reduction Device results in a significant decrease in associated infectivity.

5 Apr 2004

FDA Approves Pre-Filled Pre-Mixed Fertility Medication

The U.S. Food and Drug Administration (FDA) today announced approval of Follistim®-AQ TM cartridge (follitropin beta injection) in the United States. Follistim-AQ cartridge is the first follicle stimulating hormone (FSH) treatment available in a pre-filled, pre-mixed solution, eliminating the need for patients to mix one or more vials of medication.

24 Mar 2004

Tiny Ribozyme package could be future treatment of Hepatitis B virus

Penn State College of Medicine researchers have developed a tiny package that searches for and destroys up to 80 percent of hepatitis B virus in the livers of mice.

22 Mar 2004

Research suggests the orlistat drug could be used to fight cancer and obesity

The Burnham Institute’s Jeffrey Smith, Ph.D., has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side-effect: it inhibits cancer growth. Dr. Smith made this discovery using an activity-based proteomics screening technique developed in his laboratory that makes it possible to identify active targets and simultaneously screen for their inhibitors.

22 Mar 2004

Obesity Drug Inhibits Prostate Tumor Growth

The Burnham Institute's Jeffrey Smith, Ph.D. has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side-effect: it inhibits cancer growth. Dr. Smith made this discovery using an activity-based proteomics screening technique developed in his laboratory that makes it possible to identify active targets and simultaneously screen for their inhibitors.

22 Mar 2004